CN Stock MarketDetailed Quotes

300361 Jiangsu Aosaikang Pharmaceutical

Watchlist
  • 0.00
  • 0.000.00%
Post Market Nov 4 09:30 CST
0Market Cap0.00P/E (TTM)

Jiangsu Aosaikang Pharmaceutical Key Stats

All
YOY yoy
Hide blank lines yoy
(Q9)Sep 30, 2013
(Q6)Jun 30, 2013
(FY)Dec 31, 2012
(Q9)Sep 30, 2012
(FY)Dec 31, 2011
(FY)Dec 31, 2010
(FY)Dec 31, 2009
Total operating revenue
33.62%1.99B
1.25B
56.62%2.04B
1.49B
60.16%1.3B
36.78%813.61M
594.83M
Operating revenue
33.62%1.99B
--1.25B
56.62%2.04B
--1.49B
60.16%1.3B
36.78%813.61M
--594.83M
Other operating revenue
53.02%110.12K
----
----
--71.96K
----
----
----
Total operating cost
33.94%1.69B
1.06B
54.98%1.75B
1.26B
59.80%1.13B
35.16%708.09M
523.88M
Operating cost
22.12%130.1M
--82.28M
24.90%146.58M
--106.53M
50.82%117.35M
46.86%77.81M
--52.98M
Operating tax surcharges
32.66%30.82M
--19.35M
58.34%31.06M
--23.23M
1,188.94%19.61M
1,108.90%1.52M
--125.88K
Operating expense
34.85%1.25B
--782.12M
59.07%1.29B
--930.3M
54.21%810.82M
30.65%525.79M
--402.46M
Administration expense
38.39%266.79M
--166.16M
57.81%278.02M
--192.78M
79.56%176.18M
49.20%98.12M
--65.76M
Financial expense
-7.92%4.79M
--3.31M
42.62%6.88M
--5.2M
212.00%4.82M
66.55%1.55M
--928.41K
Asset Impairment Loss
4.26%7.04M
--4.25M
-50.49%1.35M
--6.75M
-17.41%2.73M
103.40%3.3M
--1.62M
Other net revenue
0
0
0
0
41.73%-539.87K
-133.48%-926.55K
2.77M
Fair value change income
----
----
----
----
234.17%149.88K
-117.14%-111.71K
--651.73K
Invest income
----
----
----
----
15.35%-689.74K
-138.52%-814.84K
--2.12M
Operating profit
31.86%300.11M
188.23M
67.94%287.25M
227.61M
63.53%171.04M
41.88%104.6M
73.72M
Add:Non operating Income
426.14%14.28M
--4.04M
-65.67%3.92M
--2.71M
188.18%11.41M
-31.59%3.96M
--5.79M
Less:Non operating expense
-6.21%1.56M
--943.84K
15.79%3.02M
--1.67M
537.66%2.61M
22.37%409.35K
--334.53K
-Including:Non current assets deal loss
-96.86%20.98K
----
1,313.78%1.32M
--668.85K
-59.75%93.41K
88.42%232.08K
--123.17K
Total profit
36.81%312.83M
191.32M
60.22%288.15M
228.65M
66.30%179.85M
36.59%108.15M
79.17M
Less:Income tax cost
24.98%46.28M
--28.96M
63.66%46.09M
--37.02M
104.00%28.16M
51.57%13.81M
--9.11M
Net profit
39.10%266.55M
162.36M
59.58%242.06M
191.63M
60.78%151.68M
34.65%94.34M
70.07M
Less:Minority Profit
---20.87K
----
----
----
-77.99%239.29K
16.51%1.09M
--933.17K
Net profit of parent company owners
39.11%266.57M
--162.36M
59.83%242.06M
--191.63M
62.40%151.44M
34.89%93.26M
--69.13M
Earning per share
Basic earning per share
39.56%1.27
--0.77
59.72%1.15
--0.91
63.64%0.72
--0.44
----
Diluted earning per share
39.56%1.27
--0.77
59.72%1.15
--0.91
63.64%0.72
--0.44
----
Other composite income
282.51%2M
-1.13M
106.25%387.29K
523.37K
-6.2M
Total composite income
39.76%268.55M
161.23M
66.65%242.44M
192.15M
54.21%145.48M
34.65%94.34M
70.07M
Total composite income of parent company owners
39.76%268.55M
--161.23M
66.92%242.44M
--192.15M
55.75%145.24M
34.89%93.26M
--69.13M
Total composite income of minority owners
----
----
----
----
-77.99%239.29K
16.51%1.09M
--933.17K
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
--
Unqualified opinion
--
Unqualified opinion
Unqualified opinion
Unqualified opinion
Auditor
--
--
Lixin Certified Public Accountants (Special General Partnership)
--
Lixin Certified Public Accountants (Special General Partnership)
Lixin Certified Public Accountants (Special General Partnership)
Lixin Certified Public Accountants (Special General Partnership)
(Q9)Sep 30, 2013(Q6)Jun 30, 2013(FY)Dec 31, 2012(Q9)Sep 30, 2012(FY)Dec 31, 2011(FY)Dec 31, 2010(FY)Dec 31, 2009
Total operating revenue 33.62%1.99B1.25B56.62%2.04B1.49B60.16%1.3B36.78%813.61M594.83M
Operating revenue 33.62%1.99B--1.25B56.62%2.04B--1.49B60.16%1.3B36.78%813.61M--594.83M
Other operating revenue 53.02%110.12K----------71.96K------------
Total operating cost 33.94%1.69B1.06B54.98%1.75B1.26B59.80%1.13B35.16%708.09M523.88M
Operating cost 22.12%130.1M--82.28M24.90%146.58M--106.53M50.82%117.35M46.86%77.81M--52.98M
Operating tax surcharges 32.66%30.82M--19.35M58.34%31.06M--23.23M1,188.94%19.61M1,108.90%1.52M--125.88K
Operating expense 34.85%1.25B--782.12M59.07%1.29B--930.3M54.21%810.82M30.65%525.79M--402.46M
Administration expense 38.39%266.79M--166.16M57.81%278.02M--192.78M79.56%176.18M49.20%98.12M--65.76M
Financial expense -7.92%4.79M--3.31M42.62%6.88M--5.2M212.00%4.82M66.55%1.55M--928.41K
Asset Impairment Loss 4.26%7.04M--4.25M-50.49%1.35M--6.75M-17.41%2.73M103.40%3.3M--1.62M
Other net revenue 000041.73%-539.87K-133.48%-926.55K2.77M
Fair value change income ----------------234.17%149.88K-117.14%-111.71K--651.73K
Invest income ----------------15.35%-689.74K-138.52%-814.84K--2.12M
Operating profit 31.86%300.11M188.23M67.94%287.25M227.61M63.53%171.04M41.88%104.6M73.72M
Add:Non operating Income 426.14%14.28M--4.04M-65.67%3.92M--2.71M188.18%11.41M-31.59%3.96M--5.79M
Less:Non operating expense -6.21%1.56M--943.84K15.79%3.02M--1.67M537.66%2.61M22.37%409.35K--334.53K
-Including:Non current assets deal loss -96.86%20.98K----1,313.78%1.32M--668.85K-59.75%93.41K88.42%232.08K--123.17K
Total profit 36.81%312.83M191.32M60.22%288.15M228.65M66.30%179.85M36.59%108.15M79.17M
Less:Income tax cost 24.98%46.28M--28.96M63.66%46.09M--37.02M104.00%28.16M51.57%13.81M--9.11M
Net profit 39.10%266.55M162.36M59.58%242.06M191.63M60.78%151.68M34.65%94.34M70.07M
Less:Minority Profit ---20.87K-------------77.99%239.29K16.51%1.09M--933.17K
Net profit of parent company owners 39.11%266.57M--162.36M59.83%242.06M--191.63M62.40%151.44M34.89%93.26M--69.13M
Earning per share
Basic earning per share 39.56%1.27--0.7759.72%1.15--0.9163.64%0.72--0.44----
Diluted earning per share 39.56%1.27--0.7759.72%1.15--0.9163.64%0.72--0.44----
Other composite income 282.51%2M-1.13M106.25%387.29K523.37K-6.2M
Total composite income 39.76%268.55M161.23M66.65%242.44M192.15M54.21%145.48M34.65%94.34M70.07M
Total composite income of parent company owners 39.76%268.55M--161.23M66.92%242.44M--192.15M55.75%145.24M34.89%93.26M--69.13M
Total composite income of minority owners -----------------77.99%239.29K16.51%1.09M--933.17K
Currency Unit CNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions ----Unqualified opinion--Unqualified opinionUnqualified opinionUnqualified opinion
Auditor ----Lixin Certified Public Accountants (Special General Partnership)--Lixin Certified Public Accountants (Special General Partnership)Lixin Certified Public Accountants (Special General Partnership)Lixin Certified Public Accountants (Special General Partnership)

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
CN
Overall
Symbol
Latest Price
% Chg

No Data